12 August 2026

Circular No. (36/2026) - Voluntary Withdrawal of Oxbryta (Voxelotor) from the UAE Market

Reference: CIR-2026-00000139

Voluntary Withdrawal of Oxbryta (Voxelotor) from the UAE Market

 

To all Health facilities and healthcare practitioners in Dubai's private health sector

 

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the Emirates Drug Establishment for perusal and adherence to what is stated.

 

Circular No. (36/2026) - Voluntary Withdrawal of Oxbryta (Voxelotor) from the UAE Market

 

Thanks in advance for your good co-operation

 

 Drug Control Section

Health Regulation Sector

DHA